Presentation is loading. Please wait.

Presentation is loading. Please wait.

The short term effects of an AKT inhibitor (AZD5363) on biomarkers of the AKT pathway and anti-tumour activity in a breast cancer paired biopsy study (STAKT.

Similar presentations


Presentation on theme: "The short term effects of an AKT inhibitor (AZD5363) on biomarkers of the AKT pathway and anti-tumour activity in a breast cancer paired biopsy study (STAKT."— Presentation transcript:

1 The short term effects of an AKT inhibitor (AZD5363) on biomarkers of the AKT pathway and anti-tumour activity in a breast cancer paired biopsy study (STAKT trial) Sample Management Mr Kwok-Leung Cheung Clinical Associate Professor University of Nottingham STAKT Trial Co-investigator Alison McKendryProject Manager Quintiles

2 Sample management (1) Essentially a ‘paired biopsy study’ Many samples – a) Tumour tissues (FFPE +/- fresh frozen) b) Platelet rich plasma (PRP) c) Pharmacokinetic (PK) plasma d) Hair (eyebrow) Many laboratories

3 Sample management (2) Sponsor – University of Nottingham Central laboratory – Quintiles Other laboratories – a) Histopathology, Royal Derby Hospital b) Tenovus Institute, Cardiff c) University of Nottingham d) Other external laboratories

4 Sample management (3) – Pathway Central Lab (Quintiles) Site D Site C Site B Site A ICR Covance Tenovus Cardiff FFPE PK plasma Hair PRP Frozen tissue Nottingham Bank Serum Derby – Pathology review and sectioning

5 Sample management (4) All specimens (tumour and others) are sent to Quintiles as the central laboratory. Centralised tracking system of all specimens going in and out of Quintiles. A single manual on sample logistics covers the whole pathway and all procedures regardless of individual laboratory involvements.

6

7 Tumour sample management (1) 2 tumour blocks are to be sent, one from the diagnostic core biopsy and the second from the post-treatment core biopsy (can be obtained from the operative specimen). A standard validated FFPE protocol should be used – including taking multiple cores, immediate fixation in formalin, minimum fixation of 6 hrs, processing into one block to be sent etc.

8 Tumour sample management (2) Site  Quintiles central laboratory Quintiles central lab  Derby Histopathology (for pathology review and sectioning) Derby Histopathology  Tenovus @ Cardiff (for biomarker measurements) Separate tracking between Derby and Cardiff

9 Management of other samples Site  Quintiles central laboratory  external labs as appropriate

10

11 ?


Download ppt "The short term effects of an AKT inhibitor (AZD5363) on biomarkers of the AKT pathway and anti-tumour activity in a breast cancer paired biopsy study (STAKT."

Similar presentations


Ads by Google